青春期定时对受RAS病症影响的受试者生长进展和最终身高的影响
Federica Tamburrino1, Laura Mazzanti2, Dino Gibertoni3
1Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Frontiers in endocrinology
|February 3, 2025
概括
拉索病的延迟青春期显著影响最终的身高,强调需要仔细监测和干预. 早期检测和管理对于改善这些遗传条件下的生长结果至关重要.
科学领域:
- 遗传学 是一个遗传学.
- 内分泌学 在内分泌学.
- 儿科 儿科 儿科
背景情况:
- 拉索病是一种影响RAS/MAPK通路的遗传性疾病,导致包括生长问题在内的多种症状.
- 在Noonan综合征中,青春期的发展经常被延迟,这是一个常见的RAS病,影响最终的身材.
- 青春期时间对RAS病的生长和最终身高的确切影响需要进一步研究.
研究的目的:
- 为了调查RASopathies患者青春期发作的时间.
- 评估青春期时间对生长和最终身高的影响.
- 在这个群体中确定影响青春期进展和最终身高的因素.
主要方法:
- 对103名分子确诊RAS病症患者进行了回顾性纵向研究.
- 对40名完成青春期的患者的亚组进行了人体测量,荷尔蒙和放射学数据的分析.
- 延迟青春期开始患者与正常青春期开始患者之间最终身高的比较.
主要成果:
- 晚期青春期发生在27.8%的患者中,女性更频繁.
- 与正常发育患者相比,晚期青春期开始的患者的最终身高明显较低 (p < 0.01).
- 与未接受治疗的患者相比,生长激素治疗对最终身高没有显著差异.
结论:
- 迟到的青春期开始会对RAS病的最终身高产生不利影响,往往导致不充分的追赶成长.
- 虽然大多数患者经历自发性青春期,但对生长和青春期进展的警监测至关重要.
- 优化治疗策略对于改善RASopathies患者的最终身高结果至关重要.
相关概念视频
Signs of Puberty
223
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
223
Nature and Nurture
20.4K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.4K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Polygenic Traits
64.7K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
64.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Pleiotropy
39.5K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
39.5K


